Fortune 100 executives are reportedly taking advantage of the psychedelic drug to expand their thinking. Read More
Recent Posts
- Palantir stock soared 600% on deportation policies, AI, and its contracts with the U.S. military—but Trump sent it spiraling after a call to slash costs at the Pentagon
- The downfall of AI startup Humane reveals the perils of the AI ‘race’
- Are Elon Musk’s sweeping DOGE cuts illegal? For the most part, judges say no
- AI safety advocates slam Trump administration’s reported targeting of standards agency
- Why 1,000 global companies left Russia and won’t return—no matter what Trump and Putin say
Archives
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
Recent Comments